Abstracts tagged "non-pharmacologic intervention"

Abstract Number: 930 • 2019 ACR/ARP Annual Meeting
Neurostimulation for Treatment of Drug Refractory Rheumatoid Arthritis: A First-in-Human Study Using a Novel Vagus Nerve Stimulator
Norman Gaylis¹, David Sikes ², Alan Kivitz ³, Diane Horowitz ⁴, Charles Peterfy ⁵, Yaakov Levine ⁶, David Chernoff ⁶ and Mark Genovese ⁷, ¹Arthritis and Rheumatic Disease Specialties, Aventura, FL, ²Florida Medical Clinic, Land O Lakes, FL, ³Altoona Center for Clinical Research, Duncansville, PA, ⁴Northwell Health, Manhasset, NY, ⁵Spire Sciences Inc, Boca Raton, ⁶SetPoint Medical, Valencia, CA, ⁷Stanford University, Stanford, CA
Background/Purpose: The inflammatory reflex is an endogenous neuroimmune circuit that helps regulate innate and adaptive immunity (Annu. Rev. Immunol. 2012; 30:313). Activation of this reflex by…
Abstract Number: 2792 • 2019 ACR/ARP Annual Meeting
The Need for Personalized, Non-Pharmacological Intervention Programmes in Autoimmune Connective Tissue Disorders: Results of a EULAR-Funded Scoping Review with a Nested, Descriptive Meta-Analysis
Valentin Ritschl¹, Ricardo Ferreira ², Rúben Fernandes ², Eduardo Santos ², Essi Juutila ³, Erika Mosor ¹, Kim Fligelstone ⁴, Helena Gaspar ⁵, Linda Schraven ⁶, Judy Ammerlaan ⁷, Georg Stummvoll ⁸, Maria João Salvador ², Janet Poole ⁹, Cornelia van den Ende ¹⁰, Carina Boström ¹¹ and Tanja Stamm ¹, ¹Medical University of Vienna, Vienna, Austria, ²Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal, ³Metropolia University of Applied Sciences, Helsinki, Finland, ⁴Federation of European Scleroderma Associations, Tournai, Belgium, ⁵Portuguese League Against Rheumatic Diseases, Portugal, Portugal, ⁶Federation of European Scleroderma Associations, Sweden, Sweden, ⁷University Medical Centre, Utrecht, Netherlands, ⁸Klinikum Malcherhof Baden, Baden, Austria, ⁹University of New Mexico, Albuquerque, NM, ¹⁰Sint Maartenskliniek Nijmegen, Nijmegen, Netherlands, ¹¹Karolinska Institutet, Stockholm, Sweden
Background/Purpose: Autoimmune Connective Tissue Disorders (CTDs), including Mixed Connective Tissue Disorders (MCTD), systemic sclerosis (SSc) and systemic lupus erythematous (SLE) can lead to Raynaud phenomenon,…
Abstract Number: 220 • 2019 ACR/ARP Annual Meeting
A Positive Response to Nonpharmacological Therapies in Patients with Fibromyalgia
Raveendhara Bannuru¹, Michelle Park ², Lori Lyn Price ³ and Chenchen Wang ⁴, ¹Tufts Medical Center, Boston, MA, ²Tufts University School of Medicine, Boston, MA, ³Tufts Medical Center, Tufts University, Boston, MA, ⁴Tufts Medical Center, Boston
Background/Purpose: Identifying the factors associated with response to nonpharmacological therapies in patients with fibromyalgia will help personalize treatments and provide information to improve the design…
Abstract Number: 2338 • 2018 ACR/ARHP Annual Meeting
Pharmacological and Non-Pharmacological Approaches in a Group of Osteoporotic Patients Referring to a Rehabilitation out-Patient Clinic
Pinar Borman¹, ESRA GIZEM KOYUNCU¹, Aysegul Yaman¹ and MERVE PARLAK², ¹University of Hacettepe Faculty of Medicine, Dept of PMR, Ankara, Turkey, ²University of Hacettepe Faculty of Medicine, Dept of Public Health, Ankara, Turkey
Background/Purpose: Non-pharmacologic treatments are generally kept in the background in management of osteoporosis. The aim of this retrospective study was to evaluate characteristics and frequency…
Abstract Number: 2536 • 2018 ACR/ARHP Annual Meeting
Vagus Nerve Stimulation in Patients with Rheumatoid Arthritis: 24 Month Safety and Efficacy
Frieda A. Koopman¹, Anne Musters², Marieke M.J. Backer², Danielle Gerlag², Sanda Miljko³, Simeon Grazio⁴, Sekib Sokolovic⁵, Yaakov Levine⁶, David Chernoff⁶, Niek de Vries⁷ and Paul-Peter Tak², ¹Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, ²Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, ³University Clinical Hospital, Mostar, Bosnia, ⁴Vinogradsira 29, Clinical Hospital Center Sestre Milosrdnice, Zagreb, Croatia, ⁵Rheumatology, Sarajevo University Clinical Center, Sarajevo, BA, ⁶SetPoint Medical, Inc., Valencia, CA, ⁷Dept. of Experimental Immunology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands
Background/Purpose: RA is a debilitating chronic disease with an unmet need for additional therapeutic approaches. Modulating innate neuro-immune reflex pathways by stimulation of the vagus…
Abstract Number: 2615 • 2017 ACR/ARHP Annual Meeting
Non-Pharmacological Treatment on Fatigue, Depression, Disease Activity, and Quality of Life of Systemic Lupus Erythematosus: A Systematic Review
Monthida Fangtham¹, Jacob Louis Nash², Stephanie Hyon³, Raveendhara R. Bannuru⁴ and Chenchen Wang³, ¹Internal Medicine, University of New Mexico, Albuquerque, NM, ²Health Sciences Library and Informatics Center, University of New Mexico, Albuquerque, NM, ³Rheumatology, Center of Integrative Medicine and Division of Rheumatology, Tufts Medical Center, Boston, MA, Boston, MA, ⁴Center of Integrative Medicine and Division of Rheumatology, Tufts Medical Center, Boston, MA, Boston, MA
Background/Purpose: In recent years, non-pharmacological therapies have been deemed as potentially beneficial for patients with systemic lupus erythematosus (SLE). These include complementary and integrative approaches,…
Abstract Number: 322 • 2016 ACR/ARHP Annual Meeting
The Activating Patients at Risk for Osteoporosis Study: A Randomized Trial within the Global Longitudinal Study of Osteoporosis in Women Cohort
Maria I. Danila¹, Ryan C. Outman¹, Elizabeth J. Rahn², Amy S. Mudano³, David T. Redden⁴, Peng Li⁴, Fred A. Anderson⁵, Julia P. Anderson⁶, Susan L. Greenspan⁷, Andrea Z. LaCroix^6,8, Jeri W. Nieves⁹, Stuart L. Silverman¹⁰, Ethel S. Siris¹¹, Nelson B. Watts¹², Michael J. Miller¹³, Jeffrey R. Curtis¹⁴, Amy H. Warriner³, Nicole C. Wright¹⁵ and Kenneth G. Saag¹⁶, ¹Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ²Department of Medicine, Division of Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ³University of Alabama at Birmingham, Birmingham, AL, ⁴Biostatistics, University of Alabama at Birmingham, Birmingham, AL, ⁵University of Massachusetts Medical School, Worcester, MA, ⁶Group Health Cooperative, Seattle, WA, ⁷University of Pittsburgh, Pittsburgh, PA, ⁸University of California San Diego, La Jolla, CA, ⁹Helen Hayes, West Haverstraw, NY, ¹⁰Cedars-Sinai Medical Center, Los Angeles, CA, ¹¹Columbia University Medical Center, New York, NY, ¹²Endocrinology, Diabetes & Metabolism, University of Cincinnati, Cincinnati, OH, ¹³University of Oklahoma, Tulsa, OK, ¹⁴Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ¹⁵Epidemiology, University of Alabama at Birmingham, Birmingham, AL, ¹⁶Division Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: To improve the rate of osteoporosis medication use in women with a prior fracture we developed and implemented a tailored, educational, direct-to-patient video intervention…
Abstract Number: 733 • 2016 ACR/ARHP Annual Meeting
Efficacy and Safety of Non-Biological Therapy (Non-Biological Drugs and Non-Pharmacological Interventions): A Systematic Literature Review for the 2016 Update of the ASAS/EULAR Recommendations for the Management of Axial Spondyloarthritis
Andrea Regel¹, Alexandre Sepriano², Xenofon Baraliakos¹, Désirée van der Heijde², Juergen Braun¹, Robert Landewé³, Filip van Den Bosch⁴ and Sofia Ramiro², ¹Rheumazentrum Ruhrgebiet, Herne, Germany, ²Leiden University Medical Center, Leiden, Netherlands, ³Department of Rheumatology, Amsterdam Rheumatology Center, Amsterdam, Netherlands, ⁴Rheumatology, Ghent University Hospital, Ghent, Belgium
Background/Purpose: As part of the 2016 update of the ASAS/EULAR recommendations for the management of axSpA, we performed a systematic literature review (SLR) to assess…
Abstract Number: 2206 • 2016 ACR/ARHP Annual Meeting
Data on Treatment from Brazilian Fibromyalgia Patients Registry (EpiFibro)
José E. Martinez^1,2, Marcelo C. Rezende^1,3, Eduardo Paiva^1,4, Daniel Pollak^1,5, Milton Helfenstein Jr^1,6, Jose Roberto Provenza^1,7, Aline Ranzolin^1,8, Luiz Severiano Ribeiro^1,9, Eduardo J. R. Souza^1,10, Roberto E Heymann^1,11 and Marcos Renato Assis^1,12, ¹Brazilian Society of Rheumatology, São Paulo, Brazil, ²Rheumatology, Pontificia Universidade Católica de São Paulo, Sorocaba, Brazil, ³Santa Casa de Campo Grande, Campo Grande, Brazil, ⁴Rheumatology, Universidade Federal do Parana, Curitiba Parana, Brazil, ⁵Rheumatology, Universidade Federal de São Paulo, São Paulo, Brazil, ⁶RUA JOAO DE LACERDA SOARES, 90, Universidade Federal de São Paulo, Sao Paulo, Brazil, ⁷Rheumatology, Pontifícia Universidade Católica de Campinas, Campinas, Brazil, ⁸Hospital das Clínicas - Universidade Federal de Pernambuco, Recife, Brazil, ⁹Instituto de Previdência dos Servidores do Estado de Minas Gerais, Belo Horizonte, Brazil, ¹⁰Santa Casa de Belo Horizonte, Belo Horizonte, Brazil, ¹¹Universidade Federal de São Paulo, São Paulo, Brazil, ¹²Rheumatology, Faculdade de Medicina de Marilia, Marilia, Brazil
Background/Purpose: The Brazilian registry on fibromyalgia syndrome (EpiFibro) included 810 patients who satisfied the American College of Rheumatology Classification Criteria for Fibromyalgia (ACR1990) at the…
Abstract Number: 1438 • 2015 ACR/ARHP Annual Meeting
Oral Potassium (K+) Reduces Pain in RA: A Randomized Active Control Study of Diet Based K+ Intervention
Toktam Kainifard¹, Manjit Saluja², Anuradha Venugopalan³, Raju Rane⁴ and Arvind Chopra⁵, ¹Rheumatology, PhD fellow, Pune, India, ²Clinical care, Center for Rheumatic Diseases, Pune, India, ³Rheumatology, R & D, Lab, Center for Rheumatic Diseases, Pune, India, ⁴Pathology, Pathologist, Pune, India, ⁵Rheumatology, Centre for Rheumatic Diseases, Pune 411001, India
Background/Purpose: National Health and Nutrition Survey III (1988-94,USA) data showed a low K+ body status in RA. Further information is scanty. K+ is critical to…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].